Sutro Biopharma Inc. (STRO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sutro Biopharma Inc.

    NASDAQ: STRO · Real-Time Price · USD
    1.06
    0.04 (3.92%)
    At close: Sep 05, 2025, 3:59 PM
    1.05
    -0.94%
    After-hours: Sep 05, 2025, 07:27 PM EDT

    Sutro Biopharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 62.04M 153.73M 67.77M 61.88M
    Cost of Revenue
    		 7.22M 6.82M 8.29M 9.77M
    Gross Profit
    		 54.83M 146.91M 59.48M 52.11M
    Operating Income
    		 -238.45M -89.28M -128.94M -98.52M
    Interest Income
    		 44.42M 14.51M 3.46M 577K
    Pretax Income
    		 -225.1M -88.6M -116.7M -105.54M
    Net Income
    		 -227.46M -106.79M -119.2M -105.54M
    Selling & General & Admin
    		 48.45M 62.58M 59.54M 56M
    Research & Development
    		 252.04M 180.43M 137.17M 104.4M
    Other Expenses
    		 -7.22M -6.82M -8.29M -9.77M
    Operating Expenses
    		 293.28M 236.19M 188.43M 150.63M
    Interest Expense
    		 31.07M 23.75M 3.35M 3.14M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 300.5M 243.01M 196.72M 160.4M
    Income Tax Expense
    		 2.36M 18.19M 2.5M n/a
    Shares Outstanding (Basic)
    		 76.83M 60.16M 50.74M 46.12M
    Shares Outstanding (Diluted)
    		 76.83M 60.16M 50.74M 46.12M
    EPS (Basic)
    		 -2.96 -1.78 -2.35 -2.29
    EPS (Diluted)
    		 -2.96 -1.78 -2.35 -2.29
    EBITDA
    		 -180.45M -67.92M -105.07M -97.56M
    EBIT
    		 -187.67M -74.73M -113.36M -102.4M
    Depreciation & Amortization
    		 7.22M 6.82M 8.29M 4.84M

    Add to Watchlist